NO20083789L - Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel - Google Patents

Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel

Info

Publication number
NO20083789L
NO20083789L NO20083789A NO20083789A NO20083789L NO 20083789 L NO20083789 L NO 20083789L NO 20083789 A NO20083789 A NO 20083789A NO 20083789 A NO20083789 A NO 20083789A NO 20083789 L NO20083789 L NO 20083789L
Authority
NO
Norway
Prior art keywords
vaginal
vulvar
prevention
treatment
conjugated estrogens
Prior art date
Application number
NO20083789A
Other languages
English (en)
Norwegian (no)
Inventor
Michael J Gast
Eileen Helzner
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20083789L publication Critical patent/NO20083789L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20083789A 2006-04-05 2008-09-03 Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel NO20083789L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78951706P 2006-04-05 2006-04-05
PCT/US2007/066042 WO2007118135A2 (fr) 2006-04-05 2007-04-05 Procédés de prévention et de traitement de pathologies associées à une déficience locale en œstrogènes

Publications (1)

Publication Number Publication Date
NO20083789L true NO20083789L (no) 2008-09-30

Family

ID=38523460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083789A NO20083789L (no) 2006-04-05 2008-09-03 Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel

Country Status (16)

Country Link
US (1) US20070238713A1 (fr)
EP (1) EP2004200A2 (fr)
JP (1) JP2009532505A (fr)
KR (1) KR20080108120A (fr)
CN (1) CN101415427A (fr)
AU (1) AU2007234841A1 (fr)
BR (1) BRPI0709924A2 (fr)
CA (1) CA2644913A1 (fr)
CR (1) CR10259A (fr)
EC (1) ECSP088796A (fr)
GT (1) GT200800205A (fr)
IL (1) IL193810A0 (fr)
MX (1) MX2008012880A (fr)
NO (1) NO20083789L (fr)
RU (1) RU2008136024A (fr)
WO (1) WO2007118135A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4733407A3 (fr) * 2008-12-23 2026-08-19 Quest Diagnostics Investments LLC Dosage par spectrométrie de masse pour composés estrogènes
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (fr) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Préparations et thérapies de substitution pour hormonothérapie naturelle combinée
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
EA200301023A1 (ru) * 2001-03-16 2004-02-26 Уайт Заместительная терапия эстрогенами
EP1390038A2 (fr) * 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Traitement d'etats lies a un deficit en hormones par administration de progestatifs

Also Published As

Publication number Publication date
EP2004200A2 (fr) 2008-12-24
GT200800205A (es) 2009-05-15
CN101415427A (zh) 2009-04-22
JP2009532505A (ja) 2009-09-10
MX2008012880A (es) 2008-10-13
AU2007234841A1 (en) 2007-10-18
WO2007118135A3 (fr) 2008-04-24
KR20080108120A (ko) 2008-12-11
WO2007118135A2 (fr) 2007-10-18
RU2008136024A (ru) 2010-05-10
US20070238713A1 (en) 2007-10-11
ECSP088796A (es) 2008-11-27
BRPI0709924A2 (pt) 2011-07-26
CA2644913A1 (fr) 2007-10-18
CR10259A (es) 2008-11-26
IL193810A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
MX2008012880A (es) Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local.
MX2020007226A (es) Composiciones de corticosteroides administradas oralmente.
WO2007098113A3 (fr) Inhibition de ccr3 pour angiogenèse oculaire et dégénérescence maculaire
WO2009064460A3 (fr) Systèmes de délivrance aux voies gastro-intestinales
WO2007052289A3 (fr) Nouvelle composition de comprime dispersible
CR9908A (es) Metodo para la anticoncepcion hormonal preventiva bajo demanda
WO2007143607A3 (fr) Procédé de traitement de la vaginite atrophique
WO2008122965A3 (fr) Compositions pharmaceutiques à base de cyclosporine
NI201000183A (es) Regímenes de dosificación de antiprogestina.
AR059174A1 (es) Formas farmaceuticas en forma de pelicula para usar en la cavidad bucal (obleas)
MA30602B1 (fr) Modulateurs du metabolisme, et traitement de troubles au moyen de ces modulateurs
WO2007106537A3 (fr) Aminoquinolones utilisées comme inhibiteurs de la gsk-3
CL2007003604A1 (es) Composicion farmaceutica para administrar oral que comprende el compuesto 17-aminogeldanamicina amorfo; y su uso en el tratamiento del cancer.
UA101484C2 (en) Lh liquid formulations
WO2008038003A3 (fr) Compositions pharmaceutiques
WO2007101005A3 (fr) Compositions et méthodes pour pratiquer un détachement vitreux postérieur contrôlé
EP4335501A3 (fr) Utilisation d'estriol à faibles doses
TW200738269A (en) Oral delivery of therapeutic agents using tight junction agonists
NO20090605L (no) Metode for inhibering av respirasjonsdepresjon ved bruk av positive allosteriske AMPA reseptormodulatorer
WO2009047321A3 (fr) Composition pharmaceutique pour l'administration sublinguale de progestérone, et son procédé de préparation
WO2009035634A3 (fr) Cyanoaminoquinolones et tétrazoloaminoquinolones en tant qu'inhibiteurs de gsk-3
NO20090467L (no) Tablettformuleringer med umiddelbar frigivelse av en trombinreseptorantagonist.
EP1857112A4 (fr) Composition anticancer en administration orale comprenant un liposome qui contient des phytosterols et prevention ou traitement du cancer avec le liposome
WO2010104691A3 (fr) Composés ostrogéniques et leurs procédés d'utilisation
WO2009060451A3 (fr) Dérivés de s-alkylisothiouronium utilisés dans le traitement des troubles liés à l'hypercontractilité utérine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application